Steven Cohen Alkermes Plc. Transaction History

Point72 Asset Management, L.P.

$36.6 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$28.34 - $33.63 $5.59 Million - $6.63 Million	197,142 Added 65.81%	496,719 $15.5 Million
Q1 2023 May 15, 2023	BUY	$25.31 - $29.02 $1.59 Million - $1.82 Million	62,858 Added 26.55%	299,577 $8.45 Million
Q4 2022 Feb 14, 2023	BUY	$21.94 - $26.24 $5.19 Million - $6.21 Million	236,719 New	236,719 $6.19 Million
Q2 2022 Aug 15, 2022	SELL	$26.4 - $30.54 $6.76 Million - $7.82 Million	-255,900 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$23.07 - $27.99 $5.9 Million - $7.16 Million	255,900 New	255,900 $6.73 Million
Q3 2021 Nov 15, 2021	SELL	$23.37 - $32.13 $1.84 Million - $2.53 Million	-78,700 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$18.78 - $25.15 $20 Million - $26.7 Million	-1,062,700 Reduced 93.1%	78,700 $1.93 Million
Q1 2021 May 17, 2021	BUY	$18.21 - $23.2 $7.46 Million - $9.5 Million	409,500 Added 55.95%	1,141,400 $21.3 Million
Q4 2020 Feb 16, 2021	SELL	$15.39 - $22.1 $9.42 Million - $13.5 Million	-612,011 Reduced 45.54%	731,900 $14.6 Million
Q3 2020 Nov 16, 2020	SELL	$16.16 - $20.66 $30.4 Million - $38.8 Million	-1,879,707 Reduced 58.31%	1,343,911 $22.3 Million
Q2 2020 Aug 14, 2020	BUY	$13.31 - $19.41 $29.8 Million - $43.5 Million	2,239,354 Added 227.52%	3,223,618 $62.6 Million
Q1 2020 May 15, 2020	BUY	$13.06 - $21.24 $12.4 Million - $20.2 Million	950,164 Added 2786.4%	984,264 $14.2 Million
Q4 2019 Feb 14, 2020	BUY	$17.29 - $21.74 $589,589 - $741,334	34,100 New	34,100 $696,000
Q3 2019 Nov 15, 2019	SELL	$19.51 - $24.28 $2.56 Million - $3.19 Million	-131,370 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$21.47 - $37.33 $2.82 Million - $4.9 Million	131,370 New	131,370 $2.96 Million
Q1 2019 May 15, 2019	SELL	$28.4 - $36.49 $10.4 Million - $13.4 Million	-367,700 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$27.94 - $44.61 $10.3 Million - $16.4 Million	367,700 New	367,700 $10.9 Million
Q2 2018 Aug 14, 2018	SELL	$40.56 - $51.36 $523,224 - $662,544	-12,900 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$53.61 - $67.26 $691,569 - $867,654	12,900 New	12,900 $748,000

Others Institutions Holding ALKS

# of Institutions

363

Shares Held

181M

Call Options Held

175K

Put Options Held

96.6K

Black Rock Inc. New York, NY

29.1M
Shares

$831 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

19M
Shares

$541 Million
0.01% of portfolio
Price T Rowe Associates Inc Baltimore, MD

13M
Shares

$371 Million
0.04% of portfolio
Wellington Management Group LLP Boston, MA

12.7M
Shares

$361 Million
0.06% of portfolio
State Street Corp Boston, MA

9.19M
Shares

$262 Million
0.01% of portfolio

View Full List

About Alkermes plc.

Ticker ALKS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 164,254,000
Market Cap $4.69B
Description
Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...

More about ALKS

Track Steven Cohen's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Account